U.K. trial sparks interest in dexamethasone’s potential as a treatment for severely ill COVID-19 patients
June 16, 2020 at 12:02 PM EDT
A snapshot of data from a clinical trial in the U.K. testing a commonly prescribed steroid as a treatment for some severely ill COVID-19 patients reduced deaths among those patients, a finding that sent U.S. stocks soaring on Tuesday morning.
